Trazodone Cost in Arkansas (2026): Prices, Insurance, and Savings

Trazodone (generic; the original brand Desyrel and the extended-release brand Oleptro have both been discontinued in the U.S. market) is a serotonin antagonist and reuptake inhibitor (SARI) approved by the FDA for major depressive disorder and commonly prescribed off-label at lower doses for insomnia. It is not a federally controlled substance, generic tablets have been available since patent expiration decades ago, and multiple manufacturers currently supply the U.S. market, which is the main reason its cash price is low compared with branded sleep aids. Confirm any specific dollar figure with a current pricing tool before assuming it applies to your pharmacy and plan, and see what the label establishes about storage and expiration for handling guidance.
What is actually established, and what is not
Established (stable, unlikely to change quickly):
- Trazodone is FDA-approved for major depressive disorder; insomnia use is off-label.
- Trazodone is not a Schedule II-V controlled substance under federal law.
- Only generic immediate-release trazodone tablets are currently marketed in the U.S.; brand Desyrel and the extended-release Oleptro have been discontinued.
- Compounding of trazodone by a state-licensed 503A pharmacy, based on an individual prescription, is legal under federal compounding law, subject to USP nonsterile/sterile compounding standards.
- Generic drugs, including trazodone, are treated favorably on nearly all Medicaid, Marketplace, and commercial formularies as a category, because federal Medicaid rules cap generic copays for most beneficiaries.
Not established from the material available for this page, and requiring direct verification:
- The exact current cash price of trazodone at specific Arkansas pharmacy chains or independents.
- The current Arkansas Medicaid Preferred Drug List entry and prior-authorization thresholds for trazodone (these lists are updated periodically by the Arkansas Department of Human Services).
- Which specific commercial or Marketplace insurers place trazodone on which formulary tier in 2026, and what copay applies at a specific plan.
- Current availability of trazodone on any retailer's discount generic list, since these lists change without notice.
- The exact wording and current status of any specific Arkansas telehealth statute cited for this page; the general federal and state pattern (non-controlled substances can be prescribed after a synchronous telehealth visit) is well established, but the specific act number should be confirmed against the current Arkansas statute before it is quoted to a patient.
What trazodone tends to cost, and why the exact number needs a live check
Generic trazodone is widely reported by national drug pricing trackers as one of the cheapest options in its therapeutic category, commonly in the single digits to low teens per 30-day supply for standard strengths at cash-discount pharmacies, versus branded orexin-receptor antagonists such as suvorexant, which the FDA's own approval record confirms was approved as a branded, patent-protected product with a correspondingly higher list price (FDA Drugs@FDA, suvorexant approval record). The size of that price gap is a structural feature of a generic, multi-manufacturer drug competing against a still-patented branded one, not a number this page can certify as accurate for a given Arkansas pharmacy on a given day. Before filling, compare at least two pharmacies or a discount-card tool, because generic drug cash prices are known to vary meaningfully even within the same city.
Because a specific, dated cash-price survey of Arkansas pharmacies was not available in the source material used to build this page, treat any dollar figure you see elsewhere (including older versions of pages like this one) as a starting estimate rather than a quote you can rely on.
Does Arkansas Medicaid cover trazodone?
Arkansas Medicaid, like other state Medicaid programs, operates under federal rules that generally favor low-cost generic drugs and cap copays for most beneficiaries (CMS Medicaid prescription drug benefit overview). Generic antidepressants such as trazodone are typically covered, and it is common for state Medicaid programs to apply extra review (prior authorization) for unusually high doses, pediatric use, or combinations with other sedating medications rather than for routine adult prescribing. The specific current status of trazodone on the Arkansas Medicaid Preferred Drug List, and any dose thresholds that trigger prior authorization, should be confirmed directly with Arkansas Medicaid or the prescriber's office, since preferred drug lists are revised on a regular schedule and this page cannot certify today's version.
Insurance beyond Medicaid: what is a reasonable expectation
Across Medicare Part D, Marketplace plans, and employer-sponsored insurance, generic drugs as a class are typically placed on the lowest-cost formulary tier, and CMS's plan comparison tool is the authoritative, current source for what a specific Medicare Part D plan charges for a specific drug (Medicare Plan Finder). It is reasonable to expect that a generic, decades-old drug like trazodone will be on a preferred generic tier for most Arkansas plans in 2026, but which specific insurers, which specific tier, and which specific copay apply to your plan is plan-specific information that changes at each annual enrollment cycle. Check your plan's current formulary directly rather than relying on a general statement about "most plans."
Verification checklist: stable facts vs. facts you must re-check
Consult this information before discussing trazodone costs or insurance coverage with a patient, or before revising this page.
Category A, Stable federal and clinical facts (re-check only when there is a known regulatory change)
| Fact | Where to verify |
|---|---|
| FDA-approved indication (major depressive disorder) and off-label insomnia use | Current FDA label at Drugs@FDA |
| Not a federally controlled substance | Federal Controlled Substances Act schedules; DEA |
| Only generic immediate-release tablets currently marketed (Desyrel, Oleptro discontinued) | Current FDA Orange Book / Drugs@FDA listing |
| Legality of 503A compounding with an individual prescription | FDA compounding guidance pages |
| Federal Medicaid generic-copay caps as a general rule | CMS Medicaid prescription drug benefit page |
Category B, Date-sensitive facts (re-verify at time of publication and before every patient-facing claim)
| Fact | Why it changes | Where to verify |
|---|---|---|
| Cash price at a specific Arkansas pharmacy | Manufacturer supply, pharmacy markup, and local competition shift monthly | Call the pharmacy or use a live pricing tool |
| Discount-card rate (GoodRx, SingleCare, RxSaver, Cost Plus Drugs) | Negotiated rates and participating pharmacies change | Check the app or site at time of fill |
| Arkansas Medicaid Preferred Drug List status and PA thresholds | State PDLs are revised on a set review cycle | Arkansas Medicaid / DHS pharmacy program |
| Specific insurer formulary tier and copay | Formularies reset annually and can change mid-year | The plan's current formulary document |
| Retailer generic drug list inclusion (e.g., a $4 generics program) | Retailer lists are revised without public notice | Ask the pharmacy counter directly |
| Specific state telehealth statute citation | Statutes can be amended | Arkansas General Assembly current code |
Compounded trazodone: what it is for and what it is not
Compounded trazodone, prepared by a state-licensed 503A pharmacy for an individual patient under Section 503A of the Federal Food, Drug, and Cosmetic Act, is a legitimate option for patients who need a liquid formulation, a non-standard dose strength, or who cannot tolerate an inactive ingredient in the manufactured tablet under general federal compounding rules. Compounded preparations are not FDA-approved products; the FDA does not review them for safety and effectiveness the way it reviews the manufactured tablet, so compounding is generally reserved for a documented clinical need rather than a cost-saving strategy, since compounded liquids typically cost more than the commercial generic tablet, not less. A separate category, 503B outsourcing facilities, compounds without individual prescriptions for office use under different federal rules; the FDA's outsourcing facility registry lists which facilities are registered, though it does not confirm that a given facility compounds trazodone specifically (FDA registered outsourcing facilities).
Discount programs: what they are and their real limits
National discount-card programs (GoodRx, SingleCare, RxSaver) and cash-pay online pharmacies (such as Cost Plus Drugs) generally serve Arkansas residents the same way they serve residents of other states: the card or site shows a negotiated or cost-plus price at the time you look, and that price is not insurance and does not accumulate toward a deductible. Because these rates change frequently and vary by pharmacy and zip code, this page cannot state a specific current dollar figure with confidence. Retailer "$4 generic" lists have historically included some antidepressant and sleep-adjacent generics, but these lists are set by the retailer and change without notice, so availability should be confirmed at the counter rather than assumed from an older list.
Telehealth prescribing in Arkansas
Because trazodone is not a federally controlled substance, the general pattern across states, including Arkansas, is that a licensed prescriber can evaluate a patient through a synchronous telehealth visit and send a trazodone prescription electronically to a pharmacy without the additional DEA requirements that apply to controlled substances. Arkansas has telehealth parity provisions affecting insurer reimbursement for telehealth visits; the specific statute and its current scope should be confirmed with the Arkansas State Medical Board or the prescriber's platform, since this page's source material did not include a verified, current citation for the exact law.
How trazodone's price compares with other sleep and depression options
As a general, well-established pattern, decades-old multi-manufacturer generics (trazodone, sertraline, escitalopram, zolpidem) are priced far below newer branded, patent-protected drugs (suvorexant, lemborexant). The FDA's own drug approval database confirms the branded, patent-protected regulatory status of newer agents like suvorexant, which is the structural reason those drugs carry substantially higher list prices (FDA Drugs@FDA record for suvorexant). Specific dollar comparisons should come from a current pricing tool rather than a fixed number on this page, since generic and branded cash prices both move over time.
Clinical guideline bodies have generally recommended that, for chronic insomnia, non-drug approaches such as cognitive behavioral therapy for insomnia be considered before or alongside medication, with the choice of a specific sedating medication resting on the individual's response, side-effect tolerance, and other medications, not on price alone. If you want the specific guideline language cited to a patient, that citation should be pulled fresh from the current version of the relevant society's guideline rather than from an older secondary summary.
What actually drives your out-of-pocket number
A few practical, generally applicable factors affect what you pay at the counter, regardless of the exact current price:
- Strength prescribed. Less commonly stocked strengths (150 mg, 300 mg) can carry a premium over 50 mg or 100 mg because fewer manufacturers produce them; ask your pharmacist whether tablet splitting a scored tablet is appropriate for your prescription before doing it yourself.
- Pharmacy chosen. Cash prices for the same generic drug are known to vary meaningfully even within the same zip code, so comparing two or three pharmacies, or using a discount-card comparison tool, is a reasonable step before filling.
- In-network vs. preferred pharmacy status. Many Arkansas insurance plans set a lower copay at a designated "preferred" pharmacy than at a non-preferred one; check your plan's current pharmacy network before assuming a copay.
- 30-day vs. 90-day fill. Mail-order or 90-day retail fills sometimes lower the per-unit cost by spreading a fixed dispensing fee over more tablets, though the exact savings depend on your specific plan and pharmacy.
Safety considerations that can affect cost and follow-up
Trazodone's most common side effects at sleep-promoting doses (roughly 50 to 100 mg) are morning sedation, dry mouth, dizziness, and orthostatic hypotension. Priapism is a recognized rare but serious adverse event that requires emergency care; the exact incidence figure should be confirmed against the current FDA label rather than an older secondary summary. The FDA-approved prescribing information for trazodone carries the class-wide black box warning about increased suicidality risk in patients under 25, which applies to antidepressants generally and calls for closer monitoring, particularly in the first weeks of treatment (FDA trazodone prescribing information; confirm this reflects the current label, since labels are periodically updated). Trazodone combined with other serotonergic drugs (SSRIs, SNRIs, triptans, and some others) carries a serotonin syndrome risk that a prescriber should evaluate against your full medication list; this is a reason to disclose all medications and supplements at every visit rather than a reason to avoid trazodone outright. None of this is dosing advice for an individual reader; dose selection and monitoring should be set by the prescribing clinician based on your history.
When to seek urgent care: an erection lasting more than four hours, signs of serotonin syndrome (agitation, rapid heart rate, high fever, muscle rigidity), fainting, or new or worsening suicidal thoughts are reasons to seek emergency evaluation rather than waiting for a scheduled follow-up.
Frequently asked questions
How much does trazodone cost in Arkansas?
Does Arkansas Medicaid cover trazodone?
Is compounded trazodone legal in Arkansas?
Can I get trazodone through telehealth in Arkansas?
Is brand-name trazodone (Desyrel) still available?
What dose of trazodone is typically used for sleep versus depression?
References
- FDA. Drugs@FDA record for suvorexant (Belsomra). https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204569
- Centers for Medicare & Medicaid Services. Medicaid prescription drug benefit. https://www.medicaid.gov/medicaid/prescription-drugs/index.html
- CMS. Medicare Plan Finder. https://www.medicare.gov/plan-compare/
- FDA. Registered outsourcing facilities (503B). https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- FDA. Trazodone hydrochloride prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018207s032lbl.pdf (confirm this reflects the current label revision before citing it as current)
A dedicated PubMed search for Arkansas-specific trazodone pricing or coverage data returned no directly relevant primary literature. Claims about specific cash prices, insurer tiers, and state Medicaid rules in this article should be treated as general patterns requiring current, local verification rather than as findings drawn from a peer-reviewed study.
